Prescient Therapeutics Limited(AU:PTX)
A$0.06-0.00 (-7.94%)
AU:PTX
Prescient Therapeutics Limited financials statements
A$0.06
At close:-0.00 (-7.94%)
Want to see AU:PTX full AI Analyst Report?
Prescient Therapeutics Limited (PTX) Ratios
24 Followers
Prescient Therapeutics Limited Ratios
AU:PTX's free cash flow for Q4 2026 was AU$-680.95K. For the 2026 fiscal year, AU:PTX's free cash flow was increased by AU$0.00 and operating cash flow was AU$-680.95K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.14 | 4.08 | 8.08 | 12.21 | 17.61 |
| Quick Ratio | 7.14 | 4.08 | 8.08 | 12.21 | 17.61 |
| Cash Ratio | 4.60 | 2.18 | 4.52 | 2.91 | 15.16 |
| Solvency Ratio | -3.31 | -2.31 | -3.54 | -3.44 | -5.98 |
| Operating Cash Flow Ratio | -3.68 | -2.29 | -3.19 | -3.05 | -5.33 |
| Short-Term Operating Cash Flow Coverage | -67.44 | 0.00 | -22.38 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ 11.94M | AU$ 9.73M | AU$ 16.42M | AU$ 22.71M | AU$ 13.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.02 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.28 | 1.13 | 1.08 | 1.05 |
| Debt Service Coverage Ratio | -59.75 | 0.00 | -10.51 | 0.00 | -781.95 |
| Interest Coverage Ratio | -989.90 | 0.00 | 0.00 | 0.00 | -1086.47 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.84 | 0.92 | 1.41 | 0.79 | 1.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 99.92% | 99.95% |
| EBIT Margin | 0.00% | -172.98% | -193.59% | -307.17% | -363.24% |
| EBITDA Margin | 0.00% | -172.96% | -193.59% | -307.08% | -363.17% |
| Operating Profit Margin | 0.00% | -172.98% | -193.59% | -407.17% | -375.81% |
| Pretax Profit Margin | 0.00% | -168.09% | -321.93% | -386.04% | -363.58% |
| Net Profit Margin | 0.00% | -168.09% | -221.93% | -288.51% | -270.88% |
| Continuous Operations Profit Margin | 0.00% | -68.09% | -221.93% | -288.51% | -270.88% |
| Net Income Per EBT | 67.05% | 100.00% | 68.94% | 74.74% | 74.50% |
| EBT Per EBIT | 98.61% | 97.17% | 166.30% | 94.81% | 96.75% |
| Return on Assets (ROA) | -43.01% | -50.29% | -40.40% | -24.92% | -29.04% |
| Return on Equity (ROE) | -49.31% | -64.31% | -45.60% | -26.86% | -30.53% |
| Return on Capital Employed (ROCE) | -73.98% | -66.10% | -39.76% | -37.90% | -42.23% |
| Return on Invested Capital (ROIC) | -49.23% | -26.77% | -26.92% | -28.33% | -31.47% |
| Return on Tangible Assets | -47.86% | -56.71% | -43.95% | -28.31% | -35.90% |
| Earnings Yield | -11.18% | -20.68% | -25.57% | -11.89% | -5.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 16.48 | 0.95 | 0.94 | 1.10 |
| Payables Turnover | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 589.10 | 1768.46 | 862.22 | 385.20 |
| Asset Turnover | 0.00 | 0.30 | 0.18 | 0.09 | 0.11 |
| Working Capital Turnover Ratio | 0.00 | 0.33 | 0.19 | 0.13 | 0.12 |
| Cash Conversion Cycle | -2983.58 | 22.14 | -876328.87 | -310502.94 | -131116.65 |
| Days of Sales Outstanding | 0.00 | 22.14 | 385.35 | 387.39 | 332.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2983.58 | 0.00 | 876714.22 | 310890.32 | 131448.65 |
| Operating Cycle | 0.00 | 22.14 | 385.35 | 387.39 | 332.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -2465969.00 | 0.00 | -973.73 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -2465969.00 | 0.00 | -973.73 |
| Operating Cash Flow Coverage Ratio | -32.40 | 0.00 | -22.38 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.66 | -1.99 | -2.55 | -2.28 |
| Free Cash Flow Yield | -11.54% | -20.46% | -22.96% | -10.51% | -4.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.97 | -4.84 | -3.91 | -8.41 | -19.62 |
| Price-to-Sales (P/S) Ratio | 0.00 | 8.13 | 8.68 | 24.27 | 53.15 |
| Price-to-Book (P/B) Ratio | 4.41 | 3.11 | 1.78 | 2.26 | 5.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.67 | -4.89 | -4.35 | -9.52 | -23.26 |
| Price-to-Operating Cash Flow Ratio | -8.67 | -4.89 | -4.35 | -9.52 | -23.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | 0.45 | -0.63 | -0.39 | -1.21 |
| Enterprise Value Multiple | -5.13 | -3.78 | -3.07 | -7.11 | -12.85 |
| Enterprise Value | 53.81M | 28.50M | 22.05M | 53.03M | 88.15M |
| EV to EBITDA | -5.13 | -3.78 | -3.07 | -7.11 | -12.85 |
| EV to Sales | 0.00 | 6.54 | 5.94 | 21.84 | 46.66 |
| EV to Free Cash Flow | -7.45 | -3.93 | -2.98 | -8.57 | -20.42 |
| EV to Operating Cash Flow | -7.45 | -3.93 | -2.98 | -8.57 | -20.44 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.02 | 0.04 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.59 | 0.31 | 0.25 | 0.25 |
| Revenue Per Share | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 0.67 | 1.00 | 0.69 | 0.75 | 0.75 |
| Interest Burden | 0.99 | 0.97 | 1.66 | 1.26 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.54 | 1.88 | 2.56 | 1.80 |
| SG&A to Revenue | 0.00 | 1.19 | 0.40 | 0.56 | 0.59 |
| Stock-Based Compensation to Revenue | 0.00 | 0.08 | 0.00 | 0.19 | 0.47 |
| Income Quality | 1.03 | 0.99 | 0.90 | 0.88 | 0.84 |
Currency in AUD

